Literature DB >> 32668970

Analysis of Traditional Chinese Medicine Diagnosis and Treatment Strategies for COVID-19 Based on "The Diagnosis and Treatment Program for Coronavirus Disease-2019" from Chinese Authority.

Zhi-Hui Zhao1, Yi Zhou2, Wei-Hong Li1, Qing-Song Huang2, Zhao-Hui Tang1, Han Li1.   

Abstract

In December 2019, coronavirus disease-2019 (COVID-19) broke out in Wuhan and other places. Seven versions of the Diagnosis and Treatment Program for Coronavirus Disease-2019 successively issued by the Chinese government have designated traditional Chinese medicine (TCM) as a necessary medical strategy. Based on the changes in TCM diagnosis and treatment strategies in these seven versions of Diagnosis and Treatment Program for Coronavirus Disease-2019, this paper collected data reported by the Chinese government media; analyzed the understanding of the etiology, pathogenesis, syndrome differentiation, treatment methods, and prescriptions of COVID-19 by TCM and evaluated the clinical efficacy of TCM strategies. COVID-19 is associated with TCM disease of pestilence, and its pathogenesis can be summarized as an "epidemic pathogen invading the body, followed by entering the internal organs and transforming into heat, resulting in pathogen trapping in the interior and healthy qi collapsing, and deficiency of qi and yin". Pathological processes should be emphasized in syndrome differentiation. The manifestations of qi deficiency and yin deficiency are exhibited during the recovery period. TCM strategies represented by Qing Fei Pai Du Tang have shown apparent advantages in improving symptoms, promoting virus clearance, and shortening hospitalization, as well as surprising efficacy of zero patient progressing from mild to severe cases in a TCM cabin hospital. Clinical data illustrate the effectiveness of TCM strategies proposed by the Chinese government. This major epidemic may bring new opportunities for TCM development.

Entities:  

Keywords:  COVID-19; Coronavirus Disease-2019; Diagnosis and Treatment Program for Coronavirus Disease-2019; Qing Fei Pai Du Tang; Review; Traditional Chinese Medicine Diagnosis and Treatment Strategies

Mesh:

Substances:

Year:  2020        PMID: 32668970     DOI: 10.1142/S0192415X20500500

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  7 in total

1.  Therapeutic mechanism of Toujie Quwen granules in COVID-19 based on network pharmacology.

Authors:  Ying Huang; Wen-Jiang Zheng; Yong-Shi Ni; Mian-Sha Li; Jian-Kun Chen; Xiao-Hong Liu; Xing-Hua Tan; Ji-Qiang Li
Journal:  BioData Min       Date:  2020-09-24       Impact factor: 2.522

2.  Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: A retrospective cohort study.

Authors:  Miao-Yan Shi; Shi-Qi Sun; Wei Zhang; Xing Zhang; Gui-Hua Xu; Xuan Chen; Zi-Jian Su; Xiu-Ming Song; Lu-Jiong Liu; Yi-Bao Zhang; Yi-le Zhang; Meng Sun; Qi Chen; Yan Xue; Hua Lü; Wei-An Yuan; Xiao-Rong Chen; Yun-Fei Lu
Journal:  J Integr Med       Date:  2021-01-13

Review 3.  Composition, Clinical Efficiency, and Mechanism of NHC-Approved "Three Chinese Medicines and Three Chinese Recipes" for COVID-19 Treatment.

Authors:  Ke-Yao Xia; Zeyuan Zhao; Taif Shah; Jing-Yi Wang; Zulqarnain Baloch
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

4.  Efficacy and safety of Chinese herbal medicine for pneumonia convalescence in children: A systematic review and meta-analysis.

Authors:  Jian-Ning Guo; Xue Bai; Hong-Xian Zhang; Ning Zhang; Jun-Ming Liang; Zi-Yi Guo; Xia Cui
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

5.  Hospitalization Costs of COVID-19 Cases and Their Associated Factors in Guangdong, China: A Cross-Sectional Study.

Authors:  Moran Dong; Zuyao Yang; Yingyao Chen; Jiufeng Sun; Wenjun Ma; Shouzhen Cheng; Xiaoli Sun; Jianpeng Xiao; Guanhao He; Jianxiong Hu; Jiaqi Wang; Guimin Chen; He Zhou; Lixia Yuan; Jiali Li; Xuan Li; Hui Xu; Ruijie Wang; Dengzhou Chen; Ming Fang; Tao Liu
Journal:  Front Med (Lausanne)       Date:  2021-06-11

Review 6.  A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19.

Authors:  Robert L Chapman; Shridhar V Andurkar
Journal:  Med Chem Res       Date:  2021-12-02       Impact factor: 1.965

Review 7.  Application of Big Data and Artificial Intelligence in COVID-19 Prevention, Diagnosis, Treatment and Management Decisions in China.

Authors:  Jiancheng Dong; Huiqun Wu; Dong Zhou; Kaixiang Li; Yuanpeng Zhang; Hanzhen Ji; Zhuang Tong; Shuai Lou; Zhangsuo Liu
Journal:  J Med Syst       Date:  2021-07-24       Impact factor: 4.460

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.